|
| 37681672 | Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMxâ¿¢ RNA assay. | Histol Histopathol | 2024 |
| 37199043 | High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients. | Cancer Med | 2023 |
| 37046348 | Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ERâ¿¿+â¿¿breast cancer: further results from the POETIC trial (CRUK/07/015). | Breast Cancer Res | 2023 |
| 36096872 | Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study. | Breast Cancer Res | 2022 |
| 35792080 | The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer. | J Histochem Cytochem | 2022 |
| 35526835 | Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer. | J Mol Diagn | 2022 |
| 33108242 | Molecular Drivers of Onco<i>type</i> DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study. | J Clin Oncol | 2021 |
| 34238931 | Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study. | NPJ Breast Cancer | 2021 |
| 34050920 | British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021. | Br J Dermatol | 2021 |
| 33152284 | Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. | Lancet Oncol | 2020 |
| 31892336 | Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. | Breast Cancer Res | 2019 |
| 29623677 | Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast. | Br J Surg | 2018 |
| 29917140 | Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial. | J Natl Cancer Inst | 2018 |
| 31360844 | Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer. | JNCI Cancer Spectr | 2018 |
| 29450494 | Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. | JAMA Oncol | 2018 |
| 28006839 | High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer. | Int J Cancer | 2017 |
| 28415597 | Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer. | Oncotarget | 2017 |
| 28214785 | Oncoplastic breast conservation surgery is oncologically safe when compared to wide local excision and mastectomy. | Breast | 2017 |
| 28494403 | HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. | Eur J Cancer | 2017 |
| 28423692 | The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer. | Oncotarget | 2017 |
| 27618424 | Radiotherapy-associated Pemphigus - a Rare Cause of Grade 4 Skin Toxicity. | Clin Oncol (R Coll Radiol) | 2017 |
| 26763347 | Six-year follow-up of patients treated with oncoplastic reduction mammoplasty: A cohort study. | Int J Surg | 2016 |
| 28008267 | Oncological Outcomes and Complications After Volume Replacement Oncoplastic Breast Conservations-The Glasgow Experience. | Breast Cancer (Auckl) | 2016 |
| 27657341 | The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone. | Br J Cancer | 2016 |
| 26240010 | An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions. | Ann Surg Oncol | 2015 |
| 26387144 | Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. | Ann Oncol | 2015 |
| 26078431 | Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer. | Clin Cancer Res | 2015 |
| 26215945 | Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. | J Clin Oncol | 2015 |
| 24183459 | SIRT2: tumour suppressor or tumour promoter in operable breast cancer? | Eur J Cancer | 2014 |
| 25395314 | NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. | Breast Cancer Res Treat | 2014 |
| 25039888 | Epidermal inclusion cyst following autologous breast reconstruction--an unusual cause of a breast lump. | Breast J | 2014 |
| 24967588 | Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer. | PLoS One | 2014 |
| 22733311 | Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. | Int J Cancer | 2013 |
| 24274633 | The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer. | BMC Clin Pathol | 2013 |
| 24091623 | Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. | Br J Cancer | 2013 |
| 23535839 | Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer. | Breast Cancer Res Treat | 2013 |
| 23574778 | Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer. | Hum Pathol | 2013 |
| 23523089 | Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. | Eur J Cancer | 2013 |
| 23152120 | Authors' reply. | J Pathol | 2013 |
| 21638049 | In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer. | Breast Cancer Res Treat | 2012 |
| 22747525 | Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. | Histopathology | 2012 |
| 22460268 | Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer. | Br J Cancer | 2012 |
| 22571413 | Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis. | Histopathology | 2012 |
| 22251968 | Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. | Br J Cancer | 2012 |
| 22367773 | Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. | Br J Surg | 2012 |
| 22430898 | Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression. | J Pathol | 2012 |
| 21422407 | Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. | J Clin Oncol | 2011 |
| 22689548 | Fibroelastoma of the mitral valve as a cause of embolic cerebral infarction. | BMJ Case Rep | 2011 |
| 21990413 | Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. | J Clin Oncol | 2011 |
| 21470560 | Predictive algorithms for adjuvant therapy: TransATAC. | Steroids | 2011 |